Systematic Reviews
Copyright ©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3471-3485
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3471
Table 3 Summary of changes in glycolysis in pancreatic ductal adenocarcinoma
Glycolytic enzymeEncoding geneChange in PDACImplicated pathwaysKnown inhibitorsInhibitor effect in PDAC
HexokinaseHIF2-Deoxy-D-glucose
Hexokinase I10q22UpmTor
Hexokinase II2p13UpK-ras3-BP[21]; Lonidamine, EverolimusReduced PDAC survival/induces PDAC necrosis
Hexokinase III5q35.2-Akt
Glucokinase7p15.3-p15.1
Phosphoglucose Isomerase (also known as Autocrine Motility Factor)19q13.1UpHIF; ApoptosisInsulin-like growth factor binding protein-3; Herceptin; 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazoleReduces overall cell viability and increases apoptosis rates
PhosphofructokinaseHIFAurintricarboxylic acid[191]Inhibits fatty acid synthesis in rat hepatocytes
PFK-M (muscle type)12q13.3Down
PFK-L (liver type)21q22.3Up
PFK-P (platelet type)10p15.3-p15.2Up
AldolaseHIF3-fluro-D-glucose; 4-fluro-D-glucose
Aldolase-A16p11.2Up3-[2-hydroxyethyl(methyl)amino]-2-quinoxalinecarbonitrile 1,4-dioxideReduces PDAC proliferation and tumour volume
Aldolase-B5q22Down
Aldolase-C17cen-q12Up
Triose Phosphate Isomerase12p13Up2-phosphoglycolate; D-glycerol-1-phosphate[192]
Glyceraldehyde Phosphate DehydrogenaseHIF; p53Iodoacetate[27]; gossypol[21]Reduces cell survival and induces necrosis. No effect on K-ras
GAPDHS12p13Up
GAPDHS (testes-specific)19q13.12
Phosphoglycerate KinaseHIF1,3-bisphosphoglycerate[193]
PGK1Xq13.3Up
PGK26p12.3?
Phosphoglycerate Mutasep53Inositol hexakisphosphate[194]
PGM-B1p31Up
PGM-M4p14Down
Enolasec-MycSodium fluoride[21]; D-tartonate; 3-aminoenolpyruvate 2-phosphate[195]
ENO1 (alpha)1p36.2Up
ENO2 (gamma, neuronal)12.p13Up
ENO3 (beta, muscle)17pter-p11-
Pyruvate KinaseTyrosine kinase
Isoform PK-M1 (liver/RBC)1q21-Akt/c-Myc
Isoform PK-M2 (muscle)15q22UpL-phospholactate; M2-PK-binding peptide aptamers[196]Anti-cancer effects in animal models
Dimeric form
Tetrameric form